Matt Houck has more than 10 years of experience in eCTD publishing and regulatory operations. He has worked on a variety of different products and indications. His primary area of expertise is in eCTD submissions to the US FDA including, INDs, NDAs, DMFs, and BLAs. He has also worked on eCTD submissions for EMA and Health Canada as well as IMPDs.
Before joining Halloran, Matt worked as an eCTD publisher at Pharmakey LLC and Whitsell Innovations. In his previous roles, he worked on numerous submissions with several small and midsize pharmaceutical and biotechnology companies. He delivers high-quality submissions while meeting the submission deadlines set by the FDA and by the sponsor.